Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AK › NOME › NORTON SOUND HEALTH CORPORATION

NORTON SOUND HEALTH CORPORATION

NPI: 1225101041 · NOME, AK 99762 · Critical Access Hospital · NPI assigned 11/17/2006

$63.29M
Total Medicaid Paid
382,897
Total Claims
311,252
Beneficiaries
196
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGORN, AGNELA (HOSPITAL SERVICES VP)
Parent OrganizationCRITICAL ACESS HOSPITAL
NPI Enumeration Date11/17/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 44,812 $7.52M
2019 50,260 $9.01M
2020 47,399 $8.12M
2021 81,362 $12.24M
2022 64,261 $10.77M
2023 53,002 $8.24M
2024 41,801 $7.38M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 65,238 43,067 $10.36M
99284 Emergency department visit for the evaluation and management, high severity 6,145 4,591 $5.83M
99283 Emergency department visit for the evaluation and management, moderate severity 10,346 7,887 $5.61M
80053 Comprehensive metabolic panel 15,245 12,778 $2.98M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 13,895 10,726 $2.19M
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 11,316 10,455 $1.84M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 16,049 13,496 $1.75M
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,667 4,403 $1.75M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,251 982 $1.61M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 7,607 6,990 $1.51M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 7,520 6,921 $1.48M
74177 Computed tomography, abdomen and pelvis; with contrast material 400 347 $1.17M
70450 Computed tomography, head or brain; without contrast material 821 720 $1.16M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,803 2,223 $925K
84443 Thyroid stimulating hormone (TSH) 5,461 5,031 $904K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,681 3,457 $892K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 565 525 $878K
71046 Radiologic examination, chest; 2 views 2,304 2,083 $827K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,524 2,762 $798K
81025 8,496 7,314 $749K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,370 1,687 $699K
83036 Hemoglobin; glycosylated (A1C) 5,049 4,790 $617K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3,733 2,144 $611K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 3,311 2,435 $610K
87086 Culture, bacterial; quantitative colony count, urine 5,156 4,602 $585K
J3490 Unclassified drugs 3,147 2,049 $576K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3,673 3,362 $538K
81001 6,796 5,832 $525K
96375 Therapeutic injection; each additional sequential IV push 2,418 1,790 $499K
96361 Intravenous infusion, hydration; each additional hour 2,758 2,145 $493K
85018 8,652 7,853 $491K
80061 Lipid panel 3,731 3,469 $464K
81002 11,178 9,340 $460K
82948 6,132 4,832 $420K
86141 3,008 2,601 $393K
J0561 Injection, penicillin g benzathine, 100,000 units 1,412 1,289 $362K
86803 1,868 1,772 $360K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,508 2,202 $354K
87210 3,783 3,452 $347K
82728 1,923 1,779 $338K
97161 1,306 1,262 $295K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,515 1,390 $273K
87186 1,987 1,807 $266K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 320 302 $259K
83880 1,149 972 $254K
83735 3,406 2,790 $250K
80048 Basic metabolic panel (calcium, ionized) 1,346 1,250 $240K
86780 2,212 2,074 $237K
80305 1,615 1,410 $237K
83690 2,620 2,121 $208K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,501 2,365 $192K
85027 1,796 1,644 $180K
80306 1,400 1,080 $179K
84484 1,417 1,156 $178K
84466 1,544 1,435 $176K
86481 672 633 $174K
74176 Computed tomography, abdomen and pelvis; without contrast material 61 53 $156K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 497 467 $151K
J1050 Injection, medroxyprogesterone acetate, 1 mg 754 718 $151K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 8,011 5,937 $150K
87807 1,055 973 $139K
77067 Screening mammography, bilateral, including computer-aided detection 575 555 $133K
83540 1,730 1,604 $128K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,542 3,935 $127K
71045 Radiologic examination, chest; single view 541 449 $126K
73610 283 250 $124K
87340 988 945 $124K
85610 1,642 1,327 $106K
86850 980 855 $106K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,071 4,105 $94K
J7030 Infusion, normal saline solution , 1000 cc 4,147 3,221 $91K
84702 549 386 $88K
99281 Emergency department visit for the evaluation and management, self-limited or minor 272 248 $84K
85652 1,569 1,416 $83K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 645 631 $79K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 605 561 $79K
87486 597 556 $79K
87581 597 556 $78K
77063 Screening digital breast tomosynthesis, bilateral 549 530 $77K
82977 1,091 974 $76K
88305 Level IV - Surgical pathology, gross and microscopic examination 338 313 $73K
72125 Computed tomography, cervical spine; without contrast material 47 38 $69K
73130 164 147 $67K
86480 248 244 $66K
84439 498 462 $65K
76705 Ultrasound, abdominal, real time with image documentation; limited 141 125 $64K
73562 168 144 $61K
J7120 Ringers lactate infusion, up to 1000 cc 1,617 1,242 $61K
86900 1,017 889 $59K
J2510 Injection, penicillin g procaine, aqueous, up to 600,000 units 119 114 $53K
73030 124 109 $53K
80076 352 329 $50K
36415 Collection of venous blood by venipuncture 5,667 5,041 $49K
G0378 Hospital observation service, per hour 17 12 $48K
86901 1,017 889 $48K
76801 100 91 $48K
85730 464 391 $47K
83605 457 322 $46K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 170 95 $45K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 668 560 $45K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 210 155 $44K
86702 2,328 2,202 $43K
87070 312 298 $42K
86762 328 315 $41K
J3010 Injection, fentanyl citrate, 0.1 mg 1,076 925 $41K
82550 391 318 $40K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,278 1,726 $38K
82607 367 329 $38K
J2315 Injection, naltrexone, depot form, 1 mg 14 12 $35K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,085 1,587 $32K
J7050 Infusion, normal saline solution, 250 cc 1,255 737 $30K
84703 339 297 $29K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 799 692 $27K
84100 426 356 $27K
73100 65 50 $26K
86701 2,328 2,202 $24K
70486 12 12 $24K
84145 311 255 $22K
87081 203 198 $22K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,018 1,711 $21K
83721 1,192 1,138 $19K
J2060 Injection, lorazepam, 2 mg 493 367 $18K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 588 561 $16K
J2270 Injection, morphine sulfate, up to 10 mg 899 606 $13K
82746 97 93 $13K
85014 333 315 $11K
97530 Therapeutic activities, direct patient contact, each 15 minutes 74 38 $11K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 175 141 $10K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 640 541 $9K
73630 28 24 $9K
83719 176 170 $9K
87040 43 42 $9K
87150 59 56 $8K
86706 53 52 $8K
73090 14 12 $8K
82570 94 86 $7K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 301 232 $7K
80074 17 14 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg 121 112 $6K
84512 88 80 $6K
96376 30 26 $6K
87390 502 486 $6K
82565 45 40 $5K
83550 77 70 $5K
84153 28 27 $4K
85007 79 66 $4K
86704 41 40 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg 878 750 $4K
85379 28 27 $4K
83655 27 27 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg 64 57 $4K
82951 26 26 $4K
82435 28 25 $4K
86703 37 35 $3K
86431 25 25 $3K
84132 44 41 $3K
84295 44 41 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 42 38 $3K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 72 66 $3K
82310 28 25 $3K
84075 25 22 $2K
99152 45 44 $2K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 31 24 $2K
82040 24 21 $2K
J2550 Injection, promethazine hcl, up to 50 mg 108 91 $2K
82947 36 32 $2K
J3411 Injection, thiamine hcl, 100 mg 59 53 $2K
92504 21 20 $2K
82247 42 38 $2K
J7060 5% dextrose/water (500 ml = 1 unit) 128 65 $2K
82105 13 12 $2K
86708 12 12 $2K
84520 28 25 $2K
84460 26 23 $1K
84155 24 21 $1K
84450 24 21 $1K
92567 85 78 $1K
V2750 Anti-reflective coating, per lens 69 69 $1K
V2020 Frames, purchases 43 43 $776.54
82043 15 13 $541.76
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 79 66 $449.81
90715 16 16 $401.68
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 196 171 $239.43
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 156 154 $181.57
V2745 Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens 26 26 $130.87
J1630 Injection, haloperidol, up to 5 mg 156 106 $32.80
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 1,627 1,378 $24.56
90647 12 12 $0.12
0202U Oncology (prostate), multianalyte, gene expression profiling 680 620 $0.00
87634 2,178 2,046 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 14 12 $0.00
90472 Immunization administration, each additional vaccine (list separately) 39 38 $0.00
90670 16 16 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 47 41 $0.00
0352U 1,086 1,000 $0.00
80320 1,446 1,145 $0.00